Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Obesity Is A Poor Gauge For Detecting High Cholesterol Levels In Children
With the epidemic of childhood obesity in the United States, there is concern that overweight and obese children need to be screened for chronic medical conditions, including high cholesterol levels.
generic viagra online
Increase In Thyroid Cancer Not Explained By Screening Alone
Studies have reported an increasing incidence of thyroid cancer since 1980. One possible explanation for this trend is increased detection through more widespread and aggressive use of screening tests. Researchers at the American Cancer Society analyzed thyroid cancer incidence between 1988 and 2005 using the National Cancer Institute"s (NCI"s) Surveillance Epidemiology and End Results (SEER) dataset.
News of the day
University Researchers Find New Way Of Reducing The Symptoms Of Anaphylactic Shock
A method of reducing the impact or symptoms of anaphylactic shock has been identified by university researchers.
Endocrinology

AcroMetrix Announces The Release Of OptiQual(R) GBS Positive Control For Use With Diagnostic Assays That Detect Group B Streptococcus

AcroMetrix, a leading manufacturer of quality control standards and controls for clinical diagnostic and blood testing laboratories, announced the release of the first standardized quality control for molecular Group B Streptococcus (GBS) testing. The OptiQual GBS Positive Control is designed to help clinical laboratories comply with CLIA guidelines for qualitative molecular assays that detect Group B Streptococcus DNA, ensuring accuracy and precision throughout the testing procedure. Colonization of an expectant mother with Group B Streptococcus can pose an extreme threat to the newborn, potentially causing pneumonia, sepsis, or meningitis. In order to appropriately manage prevention of GBS transmission, obstetricians and labor and delivery nurses are beginning to utilize the more rapid and sensitive methods of PCR-based GBS detection. "As rapid, point-of-care molecular assays for Group B Streptococcus begin to replace the traditional culture-screening method, doctors and clinical laboratory technologists will want appropriate quality control materials to accurately monitor the performance of their assays," says Michael J. Eck, President and CEO of AcroMetrix. "Ultimately, the goal is for doctors to more efficiently administer antibiotic prophylaxis in order to prevent GBS transmission from a mother to her newborn. AcroMetrix is dedicated to helping doctors achieve this goal by providing quality control products such as the OptiQual GBS Positive Control." The OptiQual GBS Positive Control is unassayed and contains inactivated whole Group B Streptococcus bacteria, providing a safer method of monitoring the entire molecular testing procedure from extraction through amplification and detection. Convenient and ready to use, the OptiQual GBS Positive Control is stored at refrigerated temperatures. This product is for in vitro diagnostic use. OptiQual is a registered trademark of AcroMetrix. AcroMetrix


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009